Direxion Daily S&P Biotech Bear 3X Shares (LABD)
- Previous Close
10.52 - Open
10.68 - Bid 10.90 x 1100
- Ask 11.09 x 2200
- Day's Range
10.19 - 11.38 - 52 Week Range
5.72 - 29.92 - Volume
14,432,687 - Avg. Volume
15,723,668 - Net Assets 138.43M
- NAV 10.56
- PE Ratio (TTM) --
- Yield 6.09%
- YTD Daily Total Return 9.52%
- Beta (5Y Monthly) -2.44
- Expense Ratio (net) 1.10%
The fund, under normal circumstances, invests at least 80% of the fund’s net assets in financial instruments, including swap agreements, futures contracts, or short positions, that, in combination, provide 3X daily inverse (opposite) or short exposure to the index or to ETFs that track the index, consistent with the fund’s investment objective. The index is designed to measure the performance of the biotechnology sub-industry based on the GICS. The fund is non-diversified.
Direxion Funds
Fund Family
Trading--Inverse Equity
Fund Category
138.43M
Net Assets
2015-05-28
Inception Date
Performance Overview: LABD
Trailing returns as of 4/18/2024. Category is Trading--Inverse Equity.
People Also Watch
Holdings: LABD
Sector Weightings
Related ETF News
Research Reports: LABD
AEM: Raising target price to $53.00
AGNICO EAGLE MINES LTD has an Investment Rating of SELL; a target price of $53.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of Low.
RatingBearishPrice TargetPAAS: Lowering target price to $16.00
PAN AMERICAN SILVER CORP has an Investment Rating of SELL; a target price of $16.000000; an Industry Subrating of Low; a Management Subrating of Low; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Low; and a Value Subrating of Low.
RatingBearishPrice TargetAEM: Lowering target price to $38.00
AGNICO EAGLE MINES LTD has an Investment Rating of SELL; a target price of $38.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingBearishPrice TargetAnalyst Report: Newmont Corporation
Newmont is the world's largest gold miner. It bought Goldcorp in 2019, combined its Nevada mines in a joint venture with competitor Barrick later that year, and also purchased competitor Newcrest in November 2023. Its portfolio includes 17 wholly or majority owned mines and interests in two joint ventures in the Americas, Africa, Australia and Papua New Guinea. The company is expected to produce roughly 7.3 million ounces of gold in 2023 pro forma for Newcrest on an annualized basis. Newmont also produces material amounts of copper, silver, zinc, and lead as byproducts from its various gold mines. It had about two decades of gold reserves along with significant byproduct reserves after acquiring Newcrest.
RatingBullishPrice Target